Your session is about to expire
← Back to Search
Sperm Sorting for Gender Selection in Infertility Treatment
Study Summary
This trial is testing a new way to pick gender-specific sperm for in vitro fertilization or intrauterine insemination.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have a significant fertility issue as a man.My partner and I are seeking IVF or insemination for gender selection.My partner and I are using IVF or insemination to choose our baby's gender.
- Group 1: Sperm sorting
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
To whom is this research open for enrollment?
"Acceptance to this medical trial necessitates that participants are dealing with infertility and in the age range of 18 - 89. Upwards of 2000 patients need to be enrolled before the clinical investigation can commence."
What is the magnitude of participants for this research study?
"Affirmative. Clinicaltrials.gov indicates that the study was announced on November 6th 2013 and is still actively enrolling participants as of August 11th 2022. To date, 2000 patients have been accepted from a single medical site for this trial."
Is eligibility for this trial restricted to individuals under 30 years of age?
"Conforming to this clinical trial's selection criteria, the minimum age for enrolment is 18 years old and maximum permissible age is 89."
Are there still available slots in this clinical experiment?
"Per the information on clinicaltrials.gov, this investigation is recruiting patients at this time. The initial posting of the trial was made November 6th 2013 and its latest update occurred August 11th 2022."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
Share this study with friends
Copy Link
Messenger